---
title: "ANGIODAPT trial launches with first patient enrolment"
date: "2023-12-13T13:08:30.000Z"
publishedDate: "13 décembre 2023"
summary: "iVascular has announced the initiation of its first randomised trial of an abbreviated dual antiplatelet therapy (DAPT) regimen after implantation of the angiolite drug-eluting stent (DES). The first patient was enrolled by the team of the principal investigator of the trial, Manel Sabaté (Hospital Clinic Barcelona, Barcelona, Spain) launching the ANGIODAPT global investigation."
importance: ""
sourceUrl: "https://cardiovascularnews.com/angiodapt-trial-launches-with-first-patient-enrolment/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2023-12-13-angiodapt-trial-launches-with-first-patient-enrolment"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2023/12/AngioDAPT-crop.png"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/angiodapt-trial-launches-with-first-patient-enrolment/"
---

![ANGIODAPT trial launches with first patient enrolment](https://cardiovascularnews.com/wp-content/uploads/sites/14/2023/12/AngioDAPT-crop.png)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/angiodapt-trial-launches-with-first-patient-enrolment/*

## L’essentiel

iVascular has announced the initiation of its first randomised trial of an abbreviated dual antiplatelet therapy (DAPT) regimen after implantation of the angiolite drug-eluting stent (DES). The first patient was enrolled by the team of the principal investigator of the trial, Manel Sabaté (Hospital Clinic Barcelona, Barcelona, Spain) launching the ANGIODAPT global investigation.

## Lien source

https://cardiovascularnews.com/angiodapt-trial-launches-with-first-patient-enrolment/
